MARTHA QUEZADO
Dr. Quezado’s main research interests are in the areas of neuropathology and gastrointestinal and neuroendocrine pathology. She is interested in utilizing molecular signatures to better classify tumors and therefore try improving targeted therapy. She utilizes methylation profiling of brain tumors to improve classification of tumors and potential discovery of new entities.
Confira a agenda de atividades
22 DE MARÇO | SEXTA-FEIRA
• Room 1
10:50-12:00
PLENARY SESSION 1
Opening Session
Use of methylation in Meningiomas
Treatment update on recurrent and aggressive meningioma
Targeting BRAF in pediatric brain tumors
Moderator: Andrés Cervio (Argentina)
Moderator: Clarissa Baldotto (RJ)
Moderator: ícaro Thiago de Carvalho (SP)
Opening Session
Use of methylation in Meningiomas
Speaker: Martha Quezado (Estados Unidos)
Treatment update on recurrent and aggressive meningioma
Speaker: Andreas Hottinger (Suíça)
Targeting BRAF in pediatric brain tumors
Speaker: Jason Fangusaro (Estados Unidos)
• Room 2
13:30-15:30
SESSION 2: SKULL BASE TUMORS
How to avoid complications in skull base surgery?
Open approaches for Clival Chordomas: benefits, boundaries, and considerations
Endoscopic approaches for Clival Chordomas: benefits, boundaries, and considerations
Chordomas: exploring the landscape of clinical treatment options
What is the optimal radiation therapy planning for skull base chordomas?
Radiotherapy for recurrent/unresectable functioning pituitary adenomas - endocrinological results and tumor control
Is there any role of NGS and methylation profile for skull base tumors?
Discussion
Moderator: Antonio Aversa Dutra Do Souto (RJ)
Moderator: Bernardo Peres Salvajoli (SP)
Moderator: Mauro Takao Suzuki (DF)
Moderator: Cleiton Formentin (SP)
How to avoid complications in skull base surgery?
Speaker: Gustavo Simiano Jung (PR)
Open approaches for Clival Chordomas: benefits, boundaries, and considerations
Speaker: Luis Alencar Biurrum Borba (PR)
Endoscopic approaches for Clival Chordomas: benefits, boundaries, and considerations
Speaker: João Paulo Almeida (Estados Unidos)
Chordomas: exploring the landscape of clinical treatment options
Speaker: Rodrigo Ramella Munhoz (SP)
What is the optimal radiation therapy planning for skull base chordomas?
Speaker: Samir Abdallah Hanna (SP)
Radiotherapy for recurrent/unresectable functioning pituitary adenomas - endocrinological results and tumor control
Speaker: Eduardo Weltman (SP)
Is there any role of NGS and methylation profile for skull base tumors?
Speaker: Martha Quezado (Estados Unidos)
Discussion
23 DE MARÇO | SÁBADO
• Room 1
10:50-12:00
PLENARY SESSION 3
Opening Session
Tumor Treating Fields: current role and future directions
Vaccines and IDHwt gliomas: prospects on the horizon
DNA methilation profiling as a model for precision diagnosis in neurooncology
Moderator: Guilherme Carvalhal Ribas (SP)
Moderator: Cleiton Formentin (SP)
Moderator: Roberto Abramoff (SP)
Opening Session
Tumor Treating Fields: current role and future directions
Speaker: Roger Stüpp (Estados Unidos)
Vaccines and IDHwt gliomas: prospects on the horizon
Speaker: Vinay K. Puduvalli (Estados Unidos)
DNA methilation profiling as a model for precision diagnosis in neurooncology
Speaker: Martha Quezado (Estados Unidos)
Realização
Organização
agência de turismo
PATROCÍNIO PRATA
PATROCÍNIO BRONZE
APOIO
Apoio Institucional
